GE Healthcares DaTscan (Ioflupane 123I injection) SPECT Imaging significantly affected clinical management and diagnosis of patients with a clinically uncertain Parkinsonian syndrome and can be a useful adjunct for the assessment of movement disorders, according to data presented at the American Academy of Neurology meeting this week in Honolulu.

Out of a total of 769 men with prostate cancer who opted for active surveillance in lieu of treatment, nearly half did not require any treatment within 15 years, and no patients died from the disease, a study published online in the Journal of Clinical Oncology reported.

Li Sun, PhD, associate professor of mechanical engineering at University of Houstons Cullen College of Engineering, has received a three-year, $300,000 grant from the National Science Foundation to develop a new class of contrast agents to provide color to MRI images.

The PharmEHR Summit, held in Philadelphia April 7 and 8, gathered senior executives from pharmaceutical and device manufacturers, EHR vendors and the FDA to discuss the impact of rapid EHR adoption on drug regulatory and marketing issues.

Novelos Therapeutics has completed its acquisition of Cellectar and $5.1 million financing to develop three novel cancer-targeted compounds.

Agilent Technologies is developing a series of new ultra high-field nuclear magnetic resonance (NMR) spectrometers at 850 MHz and 1GHz and has entered into a co-marketing agreement with Bridge12 Technologies for an emerging application--dynamic nuclear polarization (DNP).

If you need emergency care, Cincinnati may be the place to be, according to a study by HealthGrades, which identified the top 10 cities for emergency medicine.

The SAMMPRIS trial, initiated to compare aggressive medical therapy alone to aggressive medical management plus angioplasty combined with stenting in patients with symptomatic high-grade stenosis (70 to 99 percent) of a major intracranial artery to prevent stroke, has been halted.